Brief: Insilico Medicine Cayman Topco Evaluates Secondary Listing No Concrete Decision Made
27/05/2026 11:29
BRIEF-Insilico Medicine Cayman Topco Evaluates Secondary Listing No Concrete Decision Made May 27 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:
EVALUATES SECONDARY LISTING; NO CONCRETE DECISION MADE
REFERS TO REPORTS IN MEDIA RECENTLY RELATING TO CO'S INTENTION TO OBTAIN SECONDARY LISTING IN ABU DHABI
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7